RODINO-KLAPAC LOUISE (Chief Scientific Officer) received a stock award from SAREPTA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/11/2025ACC: 0000950170-25-037523
Officer· Chief Scientific Officer
Since Dec 2020
+21.46K
Net shares
Net buyer
$346.8K
Total sold
0
Open market trades
0B · 0S
6
Total transactions
30.42K acquired · 8.96K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+5.50K
Price / share
—
Trade value
—
% of position
7.4%
3/7/2025
74.32K→79.82K
Common Stock
Direct
Shares
−924.00
Price / share
$100.13
Trade value
$92.52K
% of position
1.2%
3/10/2025
79.82K→78.89K
Common Stock
Direct
Shares
−2.54K
Price / share
$100.13
Trade value
$254.23K
% of position
3.2%
3/10/2025
78.89K→76.36K
Common Stock
Direct
Shares
+8.28K
Price / share
—
Trade value
—
% of position
10.8%
3/10/2025
76.36K→84.63K
Total
Net shares
+10.31K
Net value
-$346.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/7/2025 | M · Option Exercise | +5.50K | — | — | 7.4% | 74.32K | 79.82K |
| Common Stock Direct | 3/10/2025 | F · Tax Withholding | −924.00 | $100.13 | $92.52K | 1.2% | 79.82K | 78.89K |
| Common Stock Direct | 3/10/2025 | F · Tax Withholding | −2.54K | $100.13 | $254.23K | 3.2% | 78.89K | 76.36K |
| Common Stock Direct | 3/10/2025 | A · Award | +8.28K | — | — | 10.8% | 76.36K | 84.63K |
| Total | +10.31K | -$346.75K | ||||||
Derivative Transactions2
Performance Stock Units
Direct
Converts to
Common Stock
5.50K shares
Shares
−5.50K
Strike price
Held after
0.00
Exercisable
—
3/7/2025
Stock Options (right to buy)
Direct
Converts to
Common Stock
16.64K shares
Shares
+16.64K
Strike price
99.69
Held after
16.64K
Exercisable
—
3/10/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance Stock Units Direct | Common Stock5.50K shares | 3/7/2025 | M · Option Exercise | −5.50K | — | 0.00 | |
| Stock Options (right to buy) Direct | Common Stock16.64K shares | 3/10/2025 | A · Award | +16.64K | 99.69 | — | 16.64K |